位置:首页 > 蛋白库 > AMT1_ALTAL
AMT1_ALTAL
ID   AMT1_ALTAL              Reviewed;        4363 AA.
AC   C9K7B5; C9K7D5; C9K7H7; Q9UVN5;
DT   18-JUL-2018, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 1.
DT   23-FEB-2022, entry version 49.
DE   RecName: Full=AM-toxin synthetase AMT1 {ECO:0000303|PubMed:10875335};
DE            EC=6.3.2.- {ECO:0000305|PubMed:10875335};
DE   AltName: Full=Cyclic peptide synthetase AMT {ECO:0000303|PubMed:10875335};
DE   AltName: Full=Nonribosomal peptide synthetase AMT1 {ECO:0000303|PubMed:17990954};
DE            Short=NRPS AMT1 {ECO:0000305};
GN   Name=AMT1 {ECO:0000303|PubMed:15066029};
GN   Synonyms=AMT {ECO:0000303|PubMed:10875335};
OS   Alternaria alternata (Alternaria rot fungus) (Torula alternata).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;
OC   Pleosporomycetidae; Pleosporales; Pleosporineae; Pleosporaceae; Alternaria;
OC   Alternaria sect. Alternaria; Alternaria alternata complex.
OX   NCBI_TaxID=5599;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, DISRUPTION PHENOTYPE, AND
RP   PATHWAY.
RC   STRAIN=M-71;
RX   PubMed=10875335; DOI=10.1094/mpmi.2000.13.7.742;
RA   Johnson R.D., Johnson L., Itoh Y., Kodama M., Otani H., Kohmoto K.;
RT   "Cloning and characterization of a cyclic peptide synthetase gene from
RT   Alternaria alternata apple pathotype whose product is involved in AM-toxin
RT   synthesis and pathogenicity.";
RL   Mol. Plant Microbe Interact. 13:742-753(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   STRAIN=NBRC 8984;
RX   PubMed=15066029; DOI=10.1111/j.1365-2958.2004.04004.x;
RA   Ito K., Tanaka T., Hatta R., Yamamoto M., Akimitsu K., Tsuge T.;
RT   "Dissection of the host range of the fungal plant pathogen Alternaria
RT   alternata by modification of secondary metabolism.";
RL   Mol. Microbiol. 52:399-411(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND INDUCTION.
RC   STRAIN=NBRC 8984;
RX   PubMed=17990954; DOI=10.1094/mpmi-20-12-1463;
RA   Harimoto Y., Hatta R., Kodama M., Yamamoto M., Otani H., Tsuge T.;
RT   "Expression profiles of genes encoded by the supernumerary chromosome
RT   controlling AM-toxin biosynthesis and pathogenicity in the apple pathotype
RT   of Alternaria alternata.";
RL   Mol. Plant Microbe Interact. 20:1463-1476(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-4175.
RC   STRAIN=NBRC 8984;
RA   Harimoto Y., Kodama M., Yamamoto M., Otani H., Tsuge T.;
RT   "A Zn(II)2Cys6 transcription regulator encoded by the AMT gene cluster
RT   negatively controls AM-toxin production in the apple pathotype of
RT   Alternaria alternata.";
RL   Submitted (OCT-2009) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION.
RX   PubMed=11570518; DOI=10.1007/s002940100233;
RA   Johnson L.J., Johnson R.D., Akamatsu H., Salamiah A., Otani H., Kohmoto K.,
RA   Kodama M.;
RT   "Spontaneous loss of a conditionally dispensable chromosome from the
RT   Alternaria alternata apple pathotype leads to loss of toxin production and
RT   pathogenicity.";
RL   Curr. Genet. 40:65-72(2001).
RN   [6]
RP   REVIEW ON HOST-SELECTIVE TOXINS.
RX   PubMed=22846083; DOI=10.1111/j.1574-6976.2012.00350.x;
RA   Tsuge T., Harimoto Y., Akimitsu K., Ohtani K., Kodama M., Akagi Y.,
RA   Egusa M., Yamamoto M., Otani H.;
RT   "Host-selective toxins produced by the plant pathogenic fungus Alternaria
RT   alternata.";
RL   FEMS Microbiol. Rev. 37:44-66(2013).
CC   -!- FUNCTION: Nonribosomal peptide synthetase; part of the gene clusters
CC       that mediate the biosynthesis of AM-toxins, host-selective toxins
CC       (HSTs) causing Alternaria blotch on apple, a worldwide distributed
CC       disease (PubMed:10875335, PubMed:17990954, PubMed:11570518). AM-toxins
CC       are cyclic depsipeptides containing the 3 residues 2-hydroxy-isovaleric
CC       acid (2-HIV), dehydroalanine, L-alanine which are common for all 3 AM-
CC       toxins I to III. The fourth precursor is L-alpha-amino-methoxyphenyl-
CC       valeric acid (L-Amv) for AM-toxin I, L-alpha-amino-phenyl-valeric acid
CC       (L-Apv) for AM-toxin II, and L-alpha-amino-hydroxyphenyl-valeric acid
CC       (L-Ahv) for AM-toxin III (Probable). AM-toxins have two target sites
CC       for affecting susceptible apple cells; they cause invagination of the
CC       plasma membrane and electrolyte loss, and chloroplast disorganization
CC       (PubMed:22846083). The non-ribosomal peptide synthetase AMT1 contains 4
CC       catalytic modules and is responsible for activation of each residue in
CC       AM-toxin (PubMed:10875335). The aldo-keto reductase AMT2 catalyzes the
CC       conversion of 2-keto-isovaleric acid (2-KIV) to 2-hydroxy-isovaleric
CC       acid (2-HIV), one of the precursor residues incorporated by AMT1 during
CC       AM-toxin biosynthesis, by reduction of its ketone to an alcohol
CC       (PubMed:15066029). The cytochrome P450 monooxygenase AMT3 and the
CC       thioesterase AMT4 are also important for AM-toxin production, but their
CC       exact function within the AM-toxin biosynthesis are not known yet
CC       (PubMed:17990954). Up to 21 proteins (including AMT1 to AMT4) are
CC       predicted to be involved in AM-toxin biosynthesis since their
CC       expression ishighly up-regulated in AM-toxin-producing cultures
CC       (PubMed:17990954). {ECO:0000269|PubMed:10875335,
CC       ECO:0000269|PubMed:11570518, ECO:0000269|PubMed:15066029,
CC       ECO:0000269|PubMed:17990954, ECO:0000303|PubMed:22846083,
CC       ECO:0000305|PubMed:10875335}.
CC   -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:10875335}.
CC   -!- INDUCTION: Expression is up-regulated more than 10 fold in toxin
CC       producing cultures. {ECO:0000269|PubMed:17990954}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module. Each module is responsible for the recognition (via the A
CC       domain) and incorporation of a single amino acid into the growing
CC       peptide product. Thus, an NRP synthetase is generally composed of one
CC       or more modules and can terminate in a thioesterase domain (TE) that
CC       releases the newly synthesized peptide from the enzyme. Occasionally,
CC       epimerase (E) domains (responsible for L- to D-amino acid conversion)
CC       are present within the NRP synthetase (By similarity). AMT1 has the
CC       following architecture: A-T-C-A-T-C-A-T-C-T-C (Probable).
CC       {ECO:0000250|UniProtKB:Q4WAZ9, ECO:0000305|PubMed:10875335}.
CC   -!- DISRUPTION PHENOTYPE: Reduces AM-toxin production to undetectable
CC       levels. {ECO:0000269|PubMed:10875335}.
CC   -!- MISCELLANEOUS: Gene clusters encoding host-selective toxins (HSTs) are
CC       localized on conditionally dispensable chromosomes (CDCs), also called
CC       supernumerary chromosomes, where they are present in multiple copies
CC       (PubMed:17990954, PubMed:11570518). The CDCs are not essential for
CC       saprophytic growth but controls host-selective pathogenicity
CC       (PubMed:17990954, PubMed:11570518). {ECO:0000269|PubMed:11570518,
CC       ECO:0000269|PubMed:17990954}.
CC   -!- SIMILARITY: Belongs to the NRP synthetase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF01762.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF184074; AAF01762.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AB525198; BAI44739.1; -; Genomic_DNA.
DR   EMBL; AB525200; BAI44801.1; -; Genomic_DNA.
DR   EMBL; AB525199; BAI44759.1; -; Genomic_DNA.
DR   SMR; C9K7B5; -.
DR   PHI-base; PHI:160; -.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   Gene3D; 1.10.1200.10; -; 4.
DR   Gene3D; 3.30.300.30; -; 4.
DR   Gene3D; 3.30.559.10; -; 4.
DR   Gene3D; 3.40.50.12780; -; 3.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   Pfam; PF00501; AMP-binding; 3.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   Pfam; PF00668; Condensation; 4.
DR   Pfam; PF00550; PP-binding; 4.
DR   SMART; SM00823; PKS_PP; 4.
DR   SUPFAM; SSF47336; SSF47336; 4.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 3.
DR   PROSITE; PS00455; AMP_BINDING; 3.
DR   PROSITE; PS50075; CARRIER; 4.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 4.
PE   2: Evidence at transcript level;
KW   Isomerase; Ligase; Phosphopantetheine; Phosphoprotein; Repeat; Virulence.
FT   CHAIN           1..4363
FT                   /note="AM-toxin synthetase AMT1"
FT                   /id="PRO_0000444812"
FT   DOMAIN          810..887
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          1884..1961
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          2977..3053
FT                   /note="Carrier 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          3730..3806
FT                   /note="Carrier 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          278..670
FT                   /note="Adenylation 1"
FT                   /evidence="ECO:0000255"
FT   REGION          926..1340
FT                   /note="Condensation 1"
FT                   /evidence="ECO:0000255"
FT   REGION          1368..1765
FT                   /note="Adenylation 2"
FT                   /evidence="ECO:0000255"
FT   REGION          1999..2410
FT                   /note="Condensation 2"
FT                   /evidence="ECO:0000255"
FT   REGION          2448..2853
FT                   /note="Adenylation 3"
FT                   /evidence="ECO:0000255"
FT   REGION          3098..3503
FT                   /note="Condensation 3"
FT                   /evidence="ECO:0000255"
FT   REGION          3850..4204
FT                   /note="Condensation 4"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         847
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         1922
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3014
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3767
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   CONFLICT        2986
FT                   /note="L -> I (in Ref. 4; BAI44801)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   4363 AA;  479692 MW;  2B1DE2FFE532F0C0 CRC64;
     MELNDDPTGK IISGVNDISL PSLSAKQVAQ SLSEQLSTSA LPAIQSFSFP PLPNGLSETF
     HDKKMDLSYA FPRKLMSALE VSSMFCAAWA IAVDRYTTND DVVFGAFLQD IPNPGLVPLR
     LKTRSETDVG GLLHYVISEI TQSCNYPYLG KEKSSELSTE RQDSHEVGAM LVFGKSGAGE
     SNVLYEKPIT CALTITCTLA GDQLHIGASY DSRVIEAPML TRVLRQFGYL ATQLADANPT
     RRLTDIAQEL NRQDLEDIWK TNMEITTESG ALIQEIFAGQ AKQRPHAIAV EAWDGVLSYG
     QLESLSTGLA HALLQLGIKD HSLIPFCLKN SKWAVVAMLG ILKANCTFVP IDSSSPWDRR
     NRILELTHAE VIITSSFMSD DNLWNTSVLC LTEETVSGFP VLSNLPGRIS GPGSAAYVLF
     TSGSTGDPKG VVVAHSAICN SLHAIGSKIG LDETSRTLQF TSLAFDISIF EILGTLIFGG
     TICVPSEDDR LTRLPEYIVS AQVNTASLTP SVARLYDAAM VPCLNTLILG GEAMTRADIK
     NWCRLPNLFN GFGPTETAIG CAMHRVHAEQ KQHSLIGRLA GIPVWVVDPS DHEVLVPFGA
     VGELVVEGTT LALGYLDDDI KTQAAFIQDP PWLLRGCGVE LPGRRGRIYK TGDLVQYNEE
     GSLLYVGRKD SDTQVKIRGN RVDLGEIESH LHECLPSRSE VVVDVVLPSD APTSSDHILA
     VFLRYEGVNT LQDSTERTIP TKLIQVPEGI QKHLYSKLPA YMVPTVYFSV AVIPKMISGK
     TDRKRLRGMA SLFSMQELAA NSSHQTVKRA PDSVIARQLQ GIWAQVLHVD PLAIGMDDSF
     FALGGDSIAA IRLVREARQT FSIGLTVADI FSFPSLGALA AIAKVIPLID PGPSPAFTSL
     RGVSSITDLL KDVAESCGLK QPSLIEDVYA CTPLQEGLLA LSSKHSGTYT VQRVLELAPD
     VDIARFQAAW ETTARCTPIM RTRIVQHVEL GLLQAVVDED IEWKTLPSEQ LDSFLLADQK
     TSMALGQPLM RYALTQGPYS GTHGSRHLVW TVHHALYDGW SLPLLLERVR QAYYGEQPQL
     SEFAPFIRWC EQDVDEDSAA RHWQTYLEEA DESALFPPLP PSITEPIEDQ QAENRWALPE
     HGTTAVTRSI VLRAAWAIVA SRYTSSNDVL FGTTVSGRGA PVPGIEEMVG PTVATVPTRC
     KIDDNKSASS FLLEVQQAAV EAIPFEQTGL KRISEIDTRL RRVREIQTFL VVQPAEYGEA
     AFEGLGKWVN GPGYYRLDVS ALTLECVLTE SGVRCVAYFD SHVIQAATVT RALAQFAHVS
     QQLCTASPNT TLGQIDVLTS SDLRDIWNWN GPLLQLAEEP LPHVDIGKQA RTRPGAIAVH
     SWDAQLTYQE LDKYSSLLAK QLLDADVKGG DIVPLYFEPS AWVVVAMLAV LKSGAAFTPI
     DTSQPEQRRN RIVSQLQPSI GLVSARHATT VFGPGWATLE VSRRALSSMP EGPLGQVDAS
     SIAWVIFTSG STGLPKGAML QHSAVHTSHR ALGATFGLCA NTRMLQFSSF AFDACVLEIV
     ATLMHGGCVC IPSELQQRSL SELPSVCAAM EVNTMVLTPT VARLFGPSDF PDLTTLVLTG
     EPLVQSDVTK WSSIAYVANG YGPAECSNIC TVHRIAPDDT DPNRIGSLRG VPNWVVHSRN
     HHQLTPIGGV GELLIEGATV GHGYLNDAEK TAAAFVTDPA WLTEISHALP CFERHGRLYK
     TGDIVKLHED GSLSYLGRKD TQIKIHGQRI ELGEIEHHVL HCTKAVEVTV DAVYVPGEEK
     NKSLVAFVRP SNGTSTPQFY DNPDAIINEL ANSLPAYMIP TMYIQVPSIP RTASGKTDRK
     QLREMGTAMA SSHAARHWKH QNRPPVTDME KHVQKLWARV LTLENAGEIS LDDSFIRLGG
     DSIAAMKLVS LAAKAGLGLT VAQIFRHTKL EDQARHVTLL TQGGPAPIAQ FSLLPDSPDV
     KALQADIARA YAIEASSIED VYPCTPLQEG LLSLSSKPSE YNTYTLQHVF ELPPTVDIQQ
     LRSAWEETIR TTDILRTRIV LHPRYGLVQV VVKEEIQWHE PANADVYIET DKQVQMVLGS
     SLVRYAISPD TGSASRKFIW TIHHALADGW TLDLILRKVK LAYSTLHTVS PVSEFRSFVK
     YITTRNTDEM VEYWKSTLGG YHSTTFPALP SSVRYAIEDS EVGQKHELPR NITLSAHPLS
     TLLRAAWAIV QSNYSNTSDV VFGEVFSGRS ASVPFIEAIV GPTMATLPVR VKIDDSELAR
     EMLDRLLTTT TQMIPHEQLG LQRISQINTD CQAACSFQTL LVIQPPASTH NGQEEPSLSF
     SGSPDYRLAT YALGIECTPA SDGYSFSCRA RFDSRVLSAQ VAERMMAQLG HVVSQLVAVT
     ASPSSSTLVS DIVLNTPQDL EKLWAWNEAV LELGEEQKHS MLLHQVFRKK ALAAPQATAI
     SSWDGECSYA QLEKLSDALA AMLTDLGIGI GLDQQLVPLC FERSMWVVVA MMAVLKTGAG
     IVPLDPAHPP SRHERILAKV GIGGCILVSP QYAQRQFGEG WTTMVVSEAS AAAVPSIHAF
     DPPTVTHLAV CWILFTSGST GEPKGIYLEH GAICASYKLL GKTLGIDKET RMLHFSAYAF
     DIATFEIIGT LMSGGCICIP SDAERLERLP QFCTTFAVNT AILTPSVARL YTPNDIPTLR
     SLCLAGEAPN KQDISTWQHR IPFLFNCYGP AEAACLAATN RIGPNDADRS ATRIGRLRGV
     PLWITAPGNC RKLAPIGAVG ELLIEGSTLA RGYLDPTQTD AAFIEDPEWL LQGPAGERSG
     RRGRLYRTGD LARYDEDGGV VYEGRKDNQV KIRGQRTELG EIEYHLSQCF PTAAEVVVEV
     ATSERDLASV TLVAFVKSRE TRDSSEKVPA GIFALPSKLE HEINRRLPLY MIPAVFVSVP
     EIPKTATDKT DRQKLRELAS VYATRAVDAP HHQPQRLPST VMEETLRDLW LKVIPVRQTA
     IGLDSNFFRL GGDSIAALKL VGQAQQAGIE LSSKDIFLNP KLVDLAACCT DRRCVKEGSR
     MVAKHATISR FSLLPINASI SSIVDEVANA CGIPPRLVED VYPCTPMQEG LMSLSSRNPG
     TYVSQIAIEL APDVLVDLFK LAWQQTVSTM PILRSRIIQH PKLGFLQAVL KEDVTWNNST
     DLDEYLETDS STPMGFGSEL SRHALVWDNS GKHIRFVWTV HHSIYDHVTL RLILDDVYDN
     YKGNERKDFQ PYTSFVRSVI SMKSSESEEF WRNACKDEGS SIFPQRSLSI RESCEDTTVE
     QSYQLCTTAT GVTMANVLHA AWAVVSSWHV GNQSIVFGTV LSGRTAPVLG IENIAGPTIA
     TAPFPVIIDP SETISNFLQR IQGQMAAVIP HAQLGLQRIS RLSSACELAC NFQTLFAVQE
     GRAMVGNSLG KLLDVNTFSM RTYALTLDCF LDTEGFHVKA SFDSRVVDQW RMESILRQFG
     AVAQQLATKA EGGELVSSIE TLNEQGWELL RRWNSHRTHK QWAVFPEDCE KPSPIGAIGE
     LLIEGPDFPS KYLEDPGARK VRSPRWMDRN GHKTVLLTGI LVAFDQNGNS IHIGQKRTTI
     SFKGQRIDVS QIERHITSFL AGTEAVVEAI AIPSAENSQS VLAVFLHRPE LADRGDNKSR
     PAICWSKDYG DIEKNLSVVF PDMVPTLYID MEAMPRTSHG DIDRSQLQTL GSLFPAEKVA
     ILRASRQKRP AVTAMQLAIR GLWASLLGAK EDTFHLDDDF FKSGGDSIGV IKLVGEARKR
     NIALAAADIF QYPKLESLAV RATENTLSQA EELEEPFSLI TSYVDDADRI EDFLSSNILS
     RIPYAREALQ DVLPCTSMQK QLFHAQGQIY RFVLDFGDAQ IDAHRLEHAV HGLIDRHAIL
     RTLFVPYQTD LLQVVVSPGK LKGRFVAETL GDGDEIEAAV ERVVSADKAD TNITGCPMPQ
     FIFLSKRSKT EGFQSKLIIA RFSHMQFDGY SVPFVIRDLA TLYAATTSNT NTLDADEERT
     LIVASETLPP APQFSSYIYA HYSTSSLERR KYWMRLLRAS YMTPITVKCD TPERIYNHTR
     YENRTVELEA WYRIASSGQS SPDDILTMAW ALTLSIASEE SDIVFGRTVA GRRALFIPHG
     GADDIMGPCV NTIPVRVQLP STTEQEEVDK SMTLRDLLAE IHKQTKETLP FESTGLDEIV
     EHYAPSIWKK KPRRWTSTVV WQDFAGMQAV QHTVHRRSGN HEPNGEEKYE KVGQEDGSVA
     LGYMDPFAAS SNVAFADLTC RVTCEIPLFD PADVAVIGRL VDGSPCFALG FAPERVPEPT
     IKRLADTLMA VVLCLAEHPE TSVKHLLRAQ RENWRSIREL PNV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024